Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection-Reference-Cited by-同舟云学术

Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection

Published:2018-11-05 Issue:11 Volume:13 Page:e0206661
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Laiño Jonathan^ORCID,Villena Julio^ORCID,Suvorov Alexander,Zelaya Hortensia,Ortiz Moyano Ramiro,Salva Susana,Alvarez Susana

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis;C Alicino;Vaccine,2017

2. The full benefits of adult pneumococcal vaccination: A systematic review;ET Cafiero-Fonseca;PLoS One,2017

3. Development of pneumococcal vaccines over the last 10 years;N Principi;Expert Opin Biol Ther,2017

4. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in infant mice;M Medina;Infect Immun,2008

5. Epidemiology, virulence factors and management of the pneumococcus;C Feldman;F1000Res,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa;Molecular Therapy - Methods & Clinical Development;2024-12

2. Development of a Recombinant Live Attenuated Influenza Vaccine Virus Expressing Pneumococcal Surface Antigen A as a Strategy for Combined Protection Against Influenza and Bacterial Coinfection Caused by Streptococcus pneumoniae;The Open Microbiology Journal;2024-06-25

3. Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines;Vaccines;2024-04-12

4. Mucosal Vaccines against Bacterial and Viral Pathogens;Epidemiology and Vaccinal Prevention;2023-09-20

5. The Respiratory Commensal Bacterium Corynebacterium pseudodiphtheriticum as a Mucosal Adjuvant for Nasal Vaccines;Vaccines;2023-03-08